secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACCENDRA HEALTH INC/VA/ (ACH)
CIK:        0000075252
Form:       8-K
Filed at:   2026-10-09T20:10:18+00:00
Accession:  0001104659-26-115043
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01, 7.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Accendra Health receives NYSE notice over sub-$1 average share price, plans to cure
--------------------------------------------------------------------------------

- NYSE notified Accendra on Oct. 6, 2026 that ACH's average closing price was below $1.00 over 30 consecutive trading days.
- Accendra has six months from the notice to regain compliance; closing price and 30-day average must be at least $1.00.
- Accendra intends to notify NYSE within 10 business days of its plan to cure, including a possible reverse stock split subject to stockholder approval.
- A reverse split, if necessary, would be subject to approval no later than the annual meeting anticipated in May 2027.
- Accendra says the notice has no immediate delisting impact and does not affect business, operations or SEC reporting obligations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/75252/000110465926115043/0001104659-26-115043-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/75252/000110465926115043/ach-20261006x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-115043

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer